ℹ️ Compiled from public regulatory records · Last regulator revision: February 25, 2026🚩 Report this page
Phosphorus
Active ingredient
Sold as N-9 · Dizziness HP · INJURY HP · Bladder Kidney Meridian… · Lycopodium Combination…
US FDA
- Drug class
- -
- Availability
- Prescription and OTC
- Routes
- Oral, Sublingual
- Markets covered
- 1
- Products on record
- 8
- FDA reports (12 mo)
- 806
Overview
Phosphorus is an active pharmaceutical ingredient. The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 8 | February 25, 2026 |
USUnited States· FDA
8 products
Uses
FOR ORAL USE ONLY
How to take
Sources & citations
- [1]FDA DailyMed · 01ebfc7a-d7d5-40… · revised February 25, 2026 [PDF]
- [2]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.